SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-013316
Filing Date
2018-05-14
Accepted
2018-05-14 09:01:30
Documents
52
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q 3/31/18 dare-10q_20180331.htm 10-Q 918064
2 EX-31.1 dare-ex311_11.htm EX-31.1 19191
3 EX-31.2 dare-ex312_13.htm EX-31.2 19189
4 EX-32.1 dare-ex321_7.htm EX-32.1 4845
5 EX-32.2 dare-ex322_8.htm EX-32.2 4905
6 GRAPHIC g201805131632007944732.jpg GRAPHIC 147455
  Complete submission text file 0001564590-18-013316.txt   3721295

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT dare-20180331.xml EX-101.INS 486550
8 XBRL TAXONOMY EXTENSION SCHEMA dare-20180331.xsd EX-101.SCH 53746
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dare-20180331_cal.xml EX-101.CAL 26475
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dare-20180331_def.xml EX-101.DEF 140451
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE dare-20180331_lab.xml EX-101.LAB 323682
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dare-20180331_pre.xml EX-101.PRE 234139
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-769-9145
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36395 | Film No.: 18828864
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1